Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. DPOH name: KHAN, SAMIR
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (16)
Results: 1-16 | Export
  1. Bruce Power
    Type: In-house Corporation
    Occurred: 2024-03-26
    Posted: 2024-04-15
    Designated public office holders:
    • Mitchell Rowe, Senior Policy Analyst, Office of Pharmaceuticals Management | Health Canada (HC)
    • Samir Khan, Director, Office of Pharmaceuticals Management | Health Canada (HC)
    • Denis Arsenault, Manager of Policy Development, Health Products and Food Branch | Health Canada (HC)
    • Dr. Michael Rosu-Myles, Director, Biological and Radiopharmaceutical Drugs | Health Canada (HC)
    • Cameron Christensen, Senior Investment Analyst, Collaborations and Net Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Sciences, Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    • Mary Boreskie, Sector Analyst, Life Sciences Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Malcolm McEwen, Director, Research and Development, Energy, Mining, and Environment | National Research Council (NRC)
    • Raphael Galea, Team Leader, Metrology | National Research Council (NRC)
    • Kate Prosser, Policy Advisor, Uranium and Radioactive Waste Division | Natural Resources Canada (NRCan)
    • Tess Wittman, Policy Analyst, Uranium and Radioactive Waste Division | Natural Resources Canada (NRCan)
    • Pui Wai Yuen, Director, Uranium and Radioactive Waste Division | Natural Resources Canada (NRCan)
    • Frédéric Beauregard-Tellier, Director General, Nuclear Energy and Infrastructure Security Branch | Natural Resources Canada (NRCan)
    Subject matters:
    • Energy
    • Health
    • Research and Development
      •
  2. Novavax Inc.
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2023-11-28
    Posted: 2023-12-15
    Designated public office holders:
    • Joel Denis, Director General | Public Health Agency of Canada (PHAC)
    • Mollie Royds, Associate Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)
    • Lakshmi Krishnan, Vice President, Life Sciences | Public Health Agency of Canada (PHAC)
    • Samir Khan, Director | Health Canada (HC)
    • Donlad Sheppard, Vice President, Infectious Disease | Public Health Agency of Canada (PHAC)
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Andrea Andrachuk, Director General | Public Services and Procurement Canada (PSPC)
    • Jocelyn Milburn, Director | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Government Procurement
    • Industry
    • Science and Technology
    • Health
      •
  3. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-08-31
    Posted: 2023-09-18
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Associate Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  4. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-11-07
    Posted: 2022-12-15
    Designated public office holders:
    • Michelle Mujoomdar, Director, Specialty Pharmaceuticals | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director, Policy Division | Health Canada (HC)
    • Daniel MacDonald, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  5. Life Sciences Ontario (LSO)
    Type: In-house Corporation
    Occurred: 2022-11-04
    Posted: 2022-11-07
    Designated public office holders:
    • Samir Khan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
    • Intellectual Property
    • Research and Development
    • Economic Development
    • Science and Technology
      •
  6. Life Sciences Ontario
    Type: Consultant
    Lobbyist: Philip Delistoyanov, 3Sixty Public Affairs
    Occurred: 2022-11-04
    Posted: 2022-11-07
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Science and Technology
    • Research and Development
    • Economic Development
    • Health
    • Industry
    • Intellectual Property
      •
  7. Life Sciences Ontario
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2022-11-04
    Posted: 2022-12-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
    • Regional Development
    • Industry
    • Intellectual Property
    • Economic Development
    • Research and Development
    • International Trade
    • Science and Technology
      •
  8. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-06-24
    Posted: 2022-06-24
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  9. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-24
    Posted: 2022-07-12
    Designated public office holders:
    • samir khan, Sr Advisor for Employment | Employment and Social Development Canada (ESDC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
    • Science and Technology
    • Research and Development
      •
  10. Life Sciences Ontario (LSO)
    Type: In-house Corporation
    Occurred: 2022-06-24
    Posted: 2022-07-15
    Designated public office holders:
    • Samir Khan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Taxation and Finance
    • Science and Technology
    • Intellectual Property
    • Industry
    • Research and Development
    • Economic Development
    • International Trade
    • Budget
    • Health
      •
  11. Life Sciences Ontario
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Occurred: 2022-06-24
    Posted: 2022-07-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Regional Development
    • Research and Development
    • Science and Technology
    • Health
    • Economic Development
    • Intellectual Property
    • Industry
    • International Trade
      •
  12. Life Sciences Ontario
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2022-06-24
    Posted: 2022-07-15
    Designated public office holders:
    • Samir Khan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • International Trade
    • Intellectual Property
    • Health
    • Regional Development
    • Research and Development
    • Science and Technology
    • Economic Development
    • Industry
      •
  13. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-16
    Posted: 2022-06-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director | Health Canada (HC)
    • Samir Khan, Director, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  14. National Convenience Stores Distributors Association / Association Nationale des Distributeurs aux Petite Surfaces Alimentaires
    Type: Consultant
    Lobbyist: ANNE KOTHAWALA
    Occurred: 2018-09-04
    Posted: 2019-01-09
    Designated public office holders:
    • Samir Khan, Senior Advisor, Tobacco Control Directorate | Health Canada (HC)
    • Siara David, Director, Tobacco Products Regulatory Office | Health Canada (HC)
    • Christine Tabib, Science Advisor, Tobacco Control Directorate | Health Canada (HC)
    Subject matters:
    • Health
    • Small Business
      •
  15. Canadian Convenience Stores Association / Association Canadienne des Depanneurs en Alimentation
    Type: In-house Organization
    Occurred: 2018-09-04
    Posted: 2018-10-15
    Designated public office holders:
    • Siara David, Director, Tobacco Products Regulatory Office | Health Canada (HC)
    • Samir Khan, Science Advisor, Tobacco Control Directorate | Health Canada (HC)
    • Christine Tabib, Science Advisor, Tobacco Control Directorate | Health Canada (HC)
    Subject matters:
    • Health
    • Small Business
      •
  16. Small Guys Cigar Group
    Type: Consultant
    Lobbyist: Henry Boyd, Stosic & Associates
    Occurred: 2018-07-27
    Posted: 2018-08-15
    Designated public office holders:
    • Samir Khan, Manager, Tobacco Control Directorate | Health Canada (HC)
    • Emanuela Fedele, Policy Manager, Tobacco Control Directorate | Health Canada (HC)
    Subject matters:
    • Health
      •
Date Modified: